BioSig Technologies, Inc. STEX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s total liabilities & equity?
- BioSig Technologies, Inc. (STEX) reported total liabilities & equity of $173.32M in Q1 2026.
- How has BioSig Technologies, Inc.'s total liabilities & equity changed year-over-year?
- BioSig Technologies, Inc.'s total liabilities & equity increased by 3823.0% year-over-year, from $4.42M to $173.32M.
- What is the long-term trend for BioSig Technologies, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), BioSig Technologies, Inc.'s total liabilities & equity has grown at a 43.9% compound annual growth rate (CAGR), from $30.39M to $187.54M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.